People with schizophrenia may experience emotions in their bodies differently than people without the disorder, according to a recent study published online in Schizophrenia Bulletin.
Schizophrenia & Psychotic Disorders
Metabolic complications of schizophrenia are significantly less common early in the course of the disease and become much more common—and difficult to treat—as schizophrenia progresses.
Children at high risk for schizophrenia may have difficulty distinguishing subtle differences in facial emotions, but these children may benefit from early interventions that teach them how to recognize emotions in faces.
The Clinical Assessment Interview for Negative Systems (CAINS) is an effective, empirically developed, and validated tool for measuring negative symptoms in schizophrenia, according to Ann M. Kring, PhD, of the University of California in Berkeley, and colleagues.
Within a few short months last year, our country mourned unimaginable losses suffered in two mass shootings that collectively took the lives of 38 adults and children — the Sandy Hook Elementary School shooting in Newtown, Connecticut, and the movie theater massacr
Research shows that the newer “atypical” or second-generation antipsychotic medications are associated with a host of metabolic side effects. This article explores whether clinicians are doing enough to monitor patients, how to develop an effective monitoring system, and how to intervene once a problem is identified.